-
Cost-Effectiveness of rhTNK-tPA vs. rt-PA for Acute Ischemic Stroke Patients Within 4.5H of Symptom Onset in China
Sep 9, 2025, 16:22 PM -
Treatment Characteristics of Breast Cancer Patients per HER2/HR Status in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2018-2022 Database Analysis
Sep 9, 2025, 16:22 PM -
Evolution of Negotiations and Contracts for Reimbursement of Pharmaceuticals in Greece Between 2020 and 2025: Onwards and Upwards
Sep 9, 2025, 16:22 PM -
Breast Cancer Overall Survival in France
Sep 9, 2025, 16:22 PM -
Impact of CFTR Modulator Initiation on Direct Medical Costs for People With Cystic Fibrosis
Sep 9, 2025, 16:22 PM -
Socioeconomic Disparities in Postpartum Depression Following Abortion Restrictions: A Difference-in-Differences Analysis of Medicaid Data Post-Dobbs
Sep 9, 2025, 16:22 PM -
Balancing Rigor and Feasibility of Real-World Data Demands in Germany Within the EU HTA Context: How Fit for Purpose Is the Routine Practice Data Collection (Anwendungsbegleitende Datenerhebung, AbD)?
Sep 9, 2025, 16:22 PM -
Integrating Stakeholder Insights Into Thematic Analysis: Enhancing Efficiency and Supporting HEOR
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Dostarlimab Plus Carboplatin-Paclitaxel in Primary Advanced or Recurrent Endometrial Cancer With Deficient Mismatch Repair (dMMR) and High Microsatellite Instability (MSI-H) in France
Sep 9, 2025, 16:22 PM -
Efficacy and Safety of Antibody-Drug Conjugates (ADCs) in Pretreated Breast Cancer: A Systematic Literature Review (SLR)
Sep 9, 2025, 16:22 PM -
Collecting Patient Preference Information (PPI) in In-Trial/Exit Interviews: Current Perspectives and Future Considerations
Sep 9, 2025, 16:22 PM -
Fragmentation in Access Pathways: A Review of HTA and Decision-Making Processes for Medicines in Finland
Sep 9, 2025, 16:22 PM -
The Socioeconomic Value of Adult Respiratory Immunization Programs in France: Can Improved Coverage Unlock Missed Gains?
Sep 9, 2025, 16:22 PM -
Patient Preferences for Type 2 Diabetes Mellitus (T2DM) Treatment: A Systematic Review of Discrete Choice Experiments Studies
Sep 9, 2025, 16:22 PM -
Dutch Cost Implications of Faricimab in Neovascular Age-Related Macular Degeneration: A Systematic Review of Treatment Interval and Injection Frequency
Sep 9, 2025, 16:22 PM -
Network Meta-Analysis of Survival Outcomes in the First-Line Treatment of Unresectable or Metastatic Melanoma: Scoping Review of Methodology
Sep 9, 2025, 16:22 PM -
A Two-Stage Bayesian Approach for Real-World Cost-Effectiveness Analysis: Combining Inverse Probability Weighting With Gamma-Beta Regression Model
Sep 9, 2025, 16:22 PM -
Physicians' and Pharmacists’ Views on Implementing Generic Medicines Standard and Biosimilar Guide
Sep 9, 2025, 16:22 PM -
Integrating Guidance Through a Whole Life-Cycle Approach: Wouldn’t It Be NICE?
Sep 9, 2025, 16:22 PM -
Unlocking Value: Assessing the Cost-Effectiveness of Pitolisant Wakix®in Portugal
Sep 9, 2025, 16:22 PM
